Uniting Patients and Researchers on the Road to Curing Type 1 Diabetes
Partnerships between patients and scientists are critical for identifying and addressing unmet research and treatment needs. This event, in partnership with Lyfebulb, convened patients, advocates, scientists, and caregivers to discuss the future of type 1 diabetes research and treatment. Panelists explored the treatment options currently available and how these different communities can work together to develop treatments that will improve the lives of patients in the near and long term. Dr. Bjarki Johannesson of the NYSCF Research Institute spoke about his team’s use of stem cells to understand the disease in a whole new light and to create cells for therapeutic applications.
Read a summary of the event and watch highlights here.
Type 1 Diabetes Panel
HOST![]() Susan L. Solomon, JD The NYSCF Research Institute |
||
MODERATOR![]() Karin Hehenberger, MD, PhD Lyfebulb CEO and Founder |
PANELIST![]() Lauren Bongiorno Diabetic Health Coach |
PANELIST![]() Bjarki Johannesson, PhD The NYSCF Senior Research Investigator |
PANELIST![]() Aaron Kowalski, PhD JDRF President & CEO |
PANELIST![]() Jennifer Ross Be Mixed Co-founder |
PANELIST![]() Stuart Weiss, MD NYU School of Medicine, Clinical Assistant Professor |
In collaboration with